Crossmark

Synthesis, 99mTc-labeling, in-vivo study and in-silico investigation of 6-amino-5-[(bis-(2-hydroxy-ethyl)-amino]methyl]2-methyl pyrimidin-4-ol as a potential probe for tumor targeting

Crossref DOI link: https://doi.org/10.1007/s10967-022-08412-z

Published Online: 2022-07-22

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Essa, Basma M. https://orcid.org/0000-0002-3141-9918
Abd-Allah, Walaa H.

Sakr, Tamer M.
Funding

Funding for this research was provided by:

Egyptian Atomic Energy Authority
License Information

Text and Data Mining valid from 2022-07-22

Version of Record valid from 2022-07-22
More Information

Article History

Received: 24 February 2022

Accepted: 20 June 2022

First Online: 22 July 2022

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below